Skip to main content
Retatrutide
Triple Receptor Agonist Research
Research use only
Metabolic Systems1 / 4
Metabolic Systems
Premium · rare in EU

Retatrutide

Retatrutide, nicknamed “GLP-3” online after its three receptor targets, is a synthetic triple-receptor agonist peptide synthesised as a GIP, GLP-1, and glucagon receptor agonist, studied in Eli Lilly Phase 2/3 metabolic research for its role in combined GIP, GLP-1, and glucagon receptor activation.

Quality information

A triple agonist peptide targeting GIP, GLP-1, and glucagon receptors — studied in advanced metabolic and weight-regulation contexts.

Research use only

For Research Use Only — Not for Human Consumption.

Investigational compound — no approved therapeutic indication.

Sold strictly for in vitro laboratory research.

Size
€69€8610 mg · Incl. VAT · €6.90 / mg
1
Storage
Store 2–8 °C. Reconstitute before use.

Up closeWeight / Metabolic Support

Retatrutide

Metabolic Systems

€6910 mgIn stock
What this peptide is for

Triple Receptor Agonist Research.

Retatrutide (CAS 2381089-83-2) combines GIP, GLP-1, and glucagon receptor activation in a single sequence. Phase 2 clinical trials have reported substantial reductions in body weight and improvements in metabolic markers. Formula C223H341N57O64S, MW 4858.60 g/mol. Strict clinical guidance required.

Linked research
  • — Jastreboff et al. — Phase 2 trial of Retatrutide: dose-dependent weight-loss endpoints
  • — Coskun et al. — GIP/GLP-1/glucagon tri-agonism and energy expenditure markers

Research context only. Not medical advice. Not for human or veterinary use.

Specification
  • 10 mg lyophilised powder per vial
  • Reconstitute with bacteriostatic water before use
  • Store lyophilised at 2–8 °C, keep from light
  • Once reconstituted, refrigerate and use within 28 days
What arrives in the box
  • One vial in the selected size
  • Tamper-evident cap with batch-coded label
  • Storage and clinician-consultation card
Pharmacology

What the research reports about this molecule.

Classic parameters from peer-reviewed literature. Not human dosing guidance — read alongside the PubMed references on /learn.

Sequence
Triple GIP/GLP-1/glucagon receptor agonist
Mechanism
Activates GIP, GLP-1, and glucagon receptors
Research domain
Metabolic, weight regulation (Eli Lilly Phase 2/3)
Reconstitution
Bacteriostatic water, USP
Storage
Sealed: 2–8 °C, away from light; reconstituted: 2–8 °C, use within 28 days
Handling & storage

From arrival to storage.

Laboratory handling notes for this compound. Peptyds products are supplied for research use only, not for human or veterinary use, so we give no dosing or administration guidance.

  1. 1

    Store the sealed vial at 2–8 °C, away from light

  2. 2

    Reconstitute with bacteriostatic water — swirl, do not shake

  3. 3

    Label the vial with its batch number and reconstitution date

  4. 4

    Refrigerate reconstituted vial; use within 28 days

Handling guide

Read the reconstitution guide

Reconstitution and storage for laboratory handling, step by step.

Reconstitution calculator

Research use only

Syringe

Peptide in vial

Bacteriostatic water

Concentration5 mg/mL

Target dose

Pull syringe to

5

units · 0.05 mL

01020304050607080901005

Concentration

5

mg/mL

Doses per vial

40

doses

U-50 2.5 · U-40 2 units

For laboratory research calculation only. Not medical or dosing advice, and not for human or veterinary use.

Others researching Weight / Metabolic Support also compare

Questions, answered plainly

Everything worth asking before you order.

Shipping, storage, quality, and when to speak to a clinician — without the runaround.

Where can I find product information?

Product pages contain product details and research information. Contact us if you have a question about an item.

Should I speak to a clinician before using a peptide?

We recommend it — especially if you are pregnant, nursing, managing a medical condition, or combining peptides with prescribed medication. Our product pages are educational. They are not medical advice and they do not replace a conversation with a qualified practitioner.

When will my order ship and arrive?

Dispatch timing can vary. We send tracking after the parcel is dispatched.

What does "research only" actually mean on a peptide label?

Research-only means the compound has not been approved by the EMA or any national medicines authority for medical use, and is sold solely for in-vitro and laboratory research. It is not a supplement, a cosmetic, or a medicine, and it carries no claims for human consumption.

Is retatrutide approved or available as a medicine?

No. Retatrutide is a triple agonist of GLP-1, GIP, and glucagon receptors developed by Eli Lilly and currently in Phase 3 trials (TRIUMPH programme). It is not approved by the EMA or FDA, so it cannot be prescribed. Phase 2 data showed up to ~24 percent body-weight reduction at 48 weeks.

What are the most common side effects of GLP-1 peptides specifically?

Across SUSTAIN, SURPASS, SURMOUNT, and TRIUMPH trials, the dominant adverse events for semaglutide, tirzepatide, and retatrutide are gastrointestinal: nausea, vomiting, diarrhoea, constipation, and abdominal discomfort, usually mild-to-moderate and concentrated during dose titration.

What's the difference between a prescription peptide and a research peptide?

A prescription peptide (e.g. Wegovy, Mounjaro, Vyleesi, Zadaxin in the relevant jurisdictions) has been through EMA or national-authority review, carries an authorised indication, and is dispensed by a pharmacy against a script. A research peptide is a reference-grade compound sold for laboratory use only.

How do I reconstitute a lyophilised peptide vial?

Bring both the lyophilised vial and the bacteriostatic water to room temperature, equalise pressure with a sterile vented needle, then inject the solvent slowly down the side of the vial. Swirl gently — never shake — until clear, and refrigerate at 2–8 °C.

How much bacteriostatic water should I add to my peptide vial?

The calculation is peptide mass (mg) ÷ desired concentration (mg/mL) = volume of bacteriostatic water in mL. For example, a 5 mg vial at 1 mg/mL needs 5 mL; at 2 mg/mL, 2.5 mL. Every Peptyds product page carries a suggested reconstitution volume tuned to the vial size.

How long does a reconstituted peptide stay stable in the fridge?

Most lyophilised peptides reconstituted with bacteriostatic water remain stable for 28–30 days at 2–8 °C, protected from light. A handful of short, fragile sequences — Epithalon among them — drop to roughly 14 days. Never freeze a reconstituted vial.

What side effects are most commonly reported across peptide research?

Across published trials and case series, the most frequent reported events are injection-site reactions (redness, induration, transient discomfort), headache, mild nausea, and temporary fatigue. GLP-1 and dual-agonist class peptides add dose-dependent gastrointestinal effects.

Who should not use peptides?

Peptides are not appropriate for anyone who is pregnant, nursing, planning conception, under 18, managing active cancer, or on immunosuppressants — and competitive athletes governed by WADA must avoid every peptide on the prohibited list. Anyone with a personal or family history of melanoma should specifically avoid melanocortin-receptor agonists.